enow.com Web Search

  1. Ads

    related to: exogenous surfactant therapy for depression

Search results

  1. Results from the WOW.Com Content Network
  2. Surfactant therapy - Wikipedia

    en.wikipedia.org/wiki/Surfactant_therapy

    Surfactant therapy is the medical administration of pulmonary surfactant that is derived from outside of the body. Pulmonary surfactant is a soap-like chemical synthesized by type II alveolar pneumocytes and is of various lipids (80% phospholipids, 5-10% cholesterol, and ∼10% surfactant-associated proteins).

  3. Fluvoxamine - Wikipedia

    en.wikipedia.org/wiki/Fluvoxamine

    Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [8] It is primarily used to treat major depressive disorder and, perhaps more-especially, obsessive–compulsive disorder (OCD), [9] but is also used to treat anxiety disorders [10] such as panic disorder, social anxiety disorder, and post-traumatic stress ...

  4. Management of depression - Wikipedia

    en.wikipedia.org/wiki/Management_of_depression

    The risk factors [110] for treatment resistant depression are: the duration of the episode of depression, severity of the episode, if bipolar, lack of improvement in symptoms within the first couple of treatment weeks, anxious or avoidant and borderline comorbidity and old age. Treatment resistant depression is best handled with a combination ...

  5. Acute respiratory distress syndrome - Wikipedia

    en.wikipedia.org/wiki/Acute_respiratory_distress...

    Complications that arise from treatment in a hospital: blood clots formed by lying down for long periods of time, weakness in muscles that are used for breathing, stress ulcers, and issues with mental health and depression. Failure of multiple organs; Pulmonary hypertension or increase in blood pressure in the main artery from the heart to the ...

  6. Biology of depression - Wikipedia

    en.wikipedia.org/wiki/Biology_of_depression

    The main limitation for the monoamine hypothesis of depression is the therapeutic lag between initiation of antidepressant treatment and perceived improvement of symptoms. One explanation for this therapeutic lag is that the initial increase in synaptic serotonin is only temporary, as firing of serotonergic neurons in the dorsal raphe adapt via ...

  7. Pulmonary surfactant (medication) - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_surfactant...

    Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. [ 1 ] Prevention is generally done in babies born at a gestational age of less than 32 weeks. [ 1 ]

  1. Ads

    related to: exogenous surfactant therapy for depression